•  
  •  
 

The Science Journal of the Lander College of Arts and Sciences

Authors

Elizer Terebelo

Abstract

Obesity, as classified by the AHA, is a chronic disorder affecting many people worldwide. Providing treatments for obesity is a multi-million-dollar industry. There are many different types of treatments offered for obesity, ranging from pills to surgeries. Ozempic has been touted as an FDA-approved supplement that can help someone lose weight. These GLP-1 agonists are used to treat type-2 diabetes and have been shown to help patients lose weight. Type-2 diabetes is a chronic illness that can lead to cardiovascular disease, stroke, kidney failure, serious eye disease, neuropathy, and many other diseases. For this reason, most risks that Ozempic would cause are outweighed by the complications that type-2 diabetes would lead to. The purpose of this study was to determine if there are any risks for the obese patient to take Ozempic to lose weight.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.